Literature DB >> 30390848

Enhanced Recovery After Surgery: Economic Impact and Value.

Lawrence Lee1, Liane S Feldman2.   

Abstract

Value in health care is defined as the best outcome that matters to the patient at the lowest cost. Therefore, a valuable intervention is one that either results in better outcomes at the same cost, the same outcomes at lower cost, or in the best-case scenario, better outcomes at lower cost. Enhanced recovery pathways (ERPs) increase value by improving clinical outcomes without increasing costs. ERPs do not increase overall costs, even when implementation and maintenance costs are considered. More research on patient-reported outcomes and other downstream effects of ERPs is required to fully characterize their true value.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Costs; Economic evaluation; Organizational culture; Patient-reported outcomes; Value

Mesh:

Year:  2018        PMID: 30390848     DOI: 10.1016/j.suc.2018.07.003

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  3 in total

1.  Enhanced Recovery After Surgery Protocol for Oblique Lumbar Interbody Fusion.

Authors:  Xiaofeng Shao; Renjie Li; Lichen Zhang; Weimin Jiang
Journal:  Indian J Orthop       Date:  2022-04-22       Impact factor: 1.033

2.  [Effectiveness of pronator quadratus muscle sparing in volar plate fixation for unstable distal radius fracture in adults].

Authors:  Xiaolin Liu; Hui Ye; Jinxing Shi
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-07-15

3.  Same day discharge following elective, minimally invasive, colorectal surgery : A review of enhanced recovery protocols and early outcomes by the SAGES Colorectal Surgical Committee with recommendations regarding patient selection, remote monitoring, and successful implementation.

Authors:  Elisabeth C McLemore; Lawrence Lee; Traci L Hedrick; Laila Rashidi; Erik P Askenasy; Daniel Popowich; Patricia Sylla
Journal:  Surg Endosc       Date:  2022-09-21       Impact factor: 3.453

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.